- Home
- ALRN vs KOSS Comparison
ALRN vs KOSS Comparison
Compare ALRN & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- KOSS
- Stock Information
- Founded
- ALRN 2001
- KOSS 1953
- Country
- ALRN United States
- KOSS United States
- Employees
- ALRN N/A
- KOSS N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- KOSS Consumer Electronics/Appliances
- Sector
- ALRN Health Care
- KOSS Consumer Staples
- Exchange
- ALRN Nasdaq
- KOSS Nasdaq
- Market Cap
- ALRN 76.9M
- KOSS 68.4M
- IPO Year
- ALRN 2017
- KOSS N/A
- Fundamental
- Price
- ALRN $1.97
- KOSS $6.62
- Analyst Decision
- ALRN Strong Buy
- KOSS
- Analyst Count
- ALRN 1
- KOSS 0
- Target Price
- ALRN $19.00
- KOSS N/A
- AVG Volume (30 Days)
- ALRN 137.2K
- KOSS 148.4K
- Earning Date
- ALRN 11-14-2024
- KOSS 01-30-2025
- Dividend Yield
- ALRN N/A
- KOSS N/A
- EPS Growth
- ALRN N/A
- KOSS N/A
- EPS
- ALRN N/A
- KOSS N/A
- Revenue
- ALRN N/A
- KOSS $12,092,999.00
- Revenue This Year
- ALRN N/A
- KOSS N/A
- Revenue Next Year
- ALRN N/A
- KOSS N/A
- P/E Ratio
- ALRN N/A
- KOSS N/A
- Revenue Growth
- ALRN N/A
- KOSS N/A
- 52 Week Low
- ALRN $1.61
- KOSS $2.27
- 52 Week High
- ALRN $7.42
- KOSS $18.73
- Technical
- Relative Strength Index (RSI)
- ALRN 41.44
- KOSS 38.21
- Support Level
- ALRN $1.90
- KOSS $6.58
- Resistance Level
- ALRN $2.17
- KOSS $7.27
- Average True Range (ATR)
- ALRN 0.18
- KOSS 0.45
- MACD
- ALRN 0.02
- KOSS -0.14
- Stochastic Oscillator
- ALRN 23.27
- KOSS 3.48
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.